Markets:

Overview

News

Currencies

International

Treasuries

Vertex Pharmaceuticals (NQ:VRTX)

453.36 -0.38 (-0.08%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vertex Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Vertex Pharma’s New Cystic Fibrosis Drug Granted Approval By EU ↗

July 01, 2025

Vertex announced on Tuesday that eligible patients in Ireland, Denmark, and Germany will have access to Alyftrek shortly after receiving regulatory approval from the relevant authorities.

Via Stocktwits

$100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗

June 30, 2025

Via Benzinga

How Do Investors Really Feel About Vertex Pharmaceuticals? ↗

June 27, 2025

Via Benzinga

3 S&P 500 Stocks with Mounting Challenges

June 27, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Via StockStory

Topics Artificial Intelligence Stocks

Vertex Pharmaceuticals Unusual Options Activity ↗

June 26, 2025

Via Benzinga

What's Driving the Market Sentiment Around Vertex Pharmaceuticals? ↗

June 04, 2025

Via Benzinga

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today ↗

May 28, 2025

Via Benzinga

Vertex and Ono Pharmaceutical Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

June 23, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 Unpopular Stocks Facing Headwinds

June 23, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Vertex Presents Positive Data for Zimislecel in Type 1 Diabetes at the American Diabetes Association 85th Scientific Sessions

June 20, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering ↗

June 20, 2025

FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research

Via Benzinga

Friday's session: gap up and gap down stock in the S&P500 index ↗

June 20, 2025

Let's have a look at what is happening on the US markets on Friday. Below you can find the S&P500 gap up and gap down stocks in today's session.

Via Chartmill

2 Growth Stocks to Buy and Hold for 10 Years ↗

June 19, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy World Trade

A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 10 Analysts ↗

June 17, 2025

Via Benzinga

3 Growth Stocks You Can Buy Right Now Without Any Hesitation ↗

June 16, 2025

Via The Motley Fool

$1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today ↗

June 10, 2025

Via Benzinga

1 Nasdaq 100 Stock for Long-Term Investors and 2 to Ignore

June 10, 2025

The Nasdaq 100 (^NDX) is home to some of the biggest success stories in tech and growth investing. However, certain stocks in the index face challenges like profitability concerns, rising costs, or...

Via StockStory

Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It ↗

June 09, 2025

Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases.

Via Benzinga

Topics Artificial Intelligence

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference

June 06, 2025

From Vertex Pharmaceuticals Incorporated

Via Business Wire

3 No-Brainer Healthcare Stocks to Buy in June ↗

June 02, 2025

Via The Motley Fool

4 Monster Stocks to Buy and Hold for the Next Decade ↗

June 02, 2025

Via The Motley Fool

Topics Artificial Intelligence World Trade

2 Top Stocks to Buy Right Now ↗

June 01, 2025

Via The Motley Fool

Topics Economy

3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow ↗

May 28, 2025

Via The Motley Fool

Topics Economy Government Law Enforcement

3 Top Growth Stocks to Buy in the Second Half of 2025 ↗

May 26, 2025

Via The Motley Fool

Topics Artificial Intelligence Government World Trade

2 Monster Growth Stocks to Buy and Hold for 10 Years ↗

May 24, 2025

Via The Motley Fool

Topics Bankruptcy

5 Health Care Stocks Whale Activity In Today's Session ↗

May 22, 2025

Via Benzinga

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗

May 21, 2025

Via The Motley Fool

Topics Economy Law Enforcement

Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years ↗

May 20, 2025

Via Benzinga

CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy? ↗

May 20, 2025

Via The Motley Fool

VRTX Q1 Earnings Call: New Product Launches and Pipeline Progress Amid Revenue Miss

May 19, 2025

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of...

Via StockStory

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 8 9

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.